Lataa...
A Clinical Perspective of Canagliflozin in the Management of Type 2 Diabetes Mellitus
OBJECTIVE: To assess the real-world efficacy and safety of the first sodium-glucose cotransporter-2 inhibitor, canagliflozin, in the treatment of patients with type 2 diabetes mellitus (T2DM). METHODS: This observational study assessed the efficacy and tolerability of canagliflozin in T2DM patients....
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Libertas Academica
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4179440/ https://ncbi.nlm.nih.gov/pubmed/25288892 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/CMED.S18182 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|